Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000013

President & COO gave up 5,144 shares (to pay taxes)

  • President & COO acquired 60,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J President & COO 2025-03-01 Grant or award +60,800 185,949 D: show line 1 in the form
Dowden Nathan J President & COO 2025-03-03 Shares withheld for taxes −5,144 $11.68 $60,075 180,805 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J President & COO 2025-03-01 Grant or award · Stock Option (Right to Buy) +90,800 90,800 D: show line 3 in the form
Loading xslF345X05/wk-form4_1741125544.xml…